VITAFOODS ASIA 2018

WATCH: Sirio Pharma discusses 10-year production plan for new plant

This content item was originally published on www.nutraingredients-asia.com, a William Reed online publication.

By Tingmin Koe contact

- Last updated on GMT

Related tags: Sirio Pharma, Manufacturing, Health food

Dietary supplements contract manufacturer Sirio Pharma has a 10-year plan lined up for its new manufacturing plant in Ma'anshan, Anhui.

NIA-GOED Omega-3 Summit

NutraIngredients, in conjunction with GOED, will be holding APAC's first ever omega-3 event in Singapore in February 2019, featuring renowned speakers from CSIRO, A*STAR, Koure, GOED and more.

Find out how to attend​.

Speaking to us at the recent Vitafoods Asia show in Singapore, Austin Gao, the APAC Sales Director of APAC Business department at Sirio Pharma reveals more about the company’s plans for the facility.

“Our business has expanded, as a result, we do not have enough space to add in extra capacities in Shantou’s existing plants.”

“This is why we acquired a new land in Ma’anshan, Anhui…The total area for this land is 240,000 square metres area.”

“We built up a ten year plan to fill up the whole area.”

The new plant went into operation four months ago. In the initial stage, the plant will focus on the production of gummy supplements.

Some of the gummy variants include liquid filled, centre-filled, swirled, and multi-coloured gummies. There are also vegetarian options, such as gummies made from carrageen and pectin, as well as sugar free and low-sugar options.

The new plant is expected to produce 2.4 billion gummies each year.

With increased production, the firm predicts that its market share for contract services in the US and Europe will grow exponentially in 2019.

Next year, the plant will launch phase two of the investment project, moving on to the production of probiotic products.

Besides detailing the ambitious production plan, Gao also told us consumer trends that were driving supplements consumption in China.

Watch the video to find out more. 

 

Related news

Show more

Related products

show more

Covid-19: A Game Changer for Probiotics

Covid-19: A Game Changer for Probiotics

Lumina Intelligence | 09-Feb-2021 | Technical / White Paper

This free whitepaper from Lumina Intelligence examines how the pandemic has impacted post-purchase consumer engagement with probiotics, the role of probiotics...

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Related suppliers

Follow us

Products

View more

Webinars

Nutra Champions Podcast

Nutra Champions Podcast